CATALYST DOSSIER · UPDATED 2026-11-06
$MTVA
biotech · convergence 1 · conviction WATCH
Price & Live Quote Loading live quote & chart…
Practice trade tools Build a reference frame, save a practice trade, or preview a draft. No brokerage order is placed.
Paper trade unavailable: missing risk-bounded frame
Reference only. Not financial advice. No brokerage order is placed.
Why $MTVA?
Quantitative
Net Income (CY2026Q2) : $-5.3M (-33.1% YoY)
Catalysts
Multi-spoke convergence : 8 convergent signals fired: finra_short, gap, sec_fda, auto_macro_adp_payrolls, auto_macro_bls_employment
Risks
Position-sizing discipline : Conviction WATCH (1 score) — size accordingly; no specific catalyst-fade risk flagged
Bear case
Squeeze unwind : Short interest can compress before retail catches the move — entry timing critical
Sympathy basket (cerebro)
QBTS via tech r=+0.98 sympathetic (score 7)
ORBS via tech r=+0.98 sympathetic (score 4)
NXPI via semis r=+0.88 sympathetic (score 9)
NVDA via semis r=+0.88 sympathetic (score 8)
TU via comms r=+0.77 sympathetic (score 11)
SKYD via comms r=+0.77 sympathetic (score 7)
Signals Firing
finra_short gap sec_fda auto_macro_adp_payrolls auto_macro_bls_employment auto_macro_durable_goods auto_macro_fx_rates auto_macro_yield_curve
Pick Track Record Date List Next-day max run Next-day close Hit +2%? 2026-11-05 sec_top_gappers +29.4% +29.4% ✓ hit 2026-11-05 sec_top_moat_emerging +29.4% +29.4% ✓ hit 2026-10-28 sec_top_gappers +9.6% +4.4% ✓ hit 2026-10-28 sec_top_moat_emerging +9.6% +4.4% ✓ hit 2026-09-09 sec_top_gappers +5.2% +0.6% ✓ hit 2026-09-09 sec_top_moat_emerging +5.2% +0.6% ✓ hit
Lifetime: 6/6 wins · hit-rate 100.0% on +2% intraday
Sympathy Basket QBTS via tech · score 7 ORBS via tech · score 4 NXPI via semis · score 9 NVDA via semis · score 8 TU via comms · score 11 SKYD via comms · score 7
Earnings Catalyst No recent earnings event.
Generate full earnings report
Auto-generated from public filings + tier-1 wires. Catalyst Edge publishes its picks
and its losses — see the
trust report and
methodology .
Not financial advice. Confirm independently before trading.